EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 93 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.24 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $128,469 | +14.6% | 17,061 | -4.1% | 0.00% | – |
| Q2 2022 | $112,121 | -3.8% | 17,797 | +26.8% | 0.00% | – |
| Q1 2022 | $116,491 | +94.2% | 14,035 | +21.4% | 0.00% | – |
| Q4 2021 | $60,000 | -67.9% | 11,564 | -47.2% | 0.00% | – |
| Q2 2021 | $187,000 | +9.4% | 21,902 | +13.1% | 0.00% | – |
| Q1 2021 | $171,000 | -31.0% | 19,361 | -4.1% | 0.00% | – |
| Q4 2020 | $248,000 | +90.8% | 20,185 | +26.1% | 0.00% | – |
| Q3 2020 | $130,000 | -9.7% | 16,002 | +7.4% | 0.00% | – |
| Q2 2020 | $144,000 | +29.7% | 14,904 | -8.3% | 0.00% | – |
| Q1 2020 | $111,000 | -50.4% | 16,258 | +8.3% | 0.00% | – |
| Q4 2019 | $224,000 | +31.8% | 15,008 | -7.2% | 0.00% | – |
| Q3 2019 | $170,000 | 0.0% | 16,164 | +0.5% | 0.00% | – |
| Q2 2019 | $170,000 | +5566.7% | 16,081 | +4379.4% | 0.00% | – |
| Q2 2017 | $3,000 | -25.0% | 359 | +10.1% | 0.00% | – |
| Q1 2017 | $4,000 | 0.0% | 326 | 0.0% | 0.00% | – |
| Q4 2016 | $4,000 | 0.0% | 326 | 0.0% | 0.00% | – |
| Q3 2016 | $4,000 | +300.0% | 326 | +608.7% | 0.00% | – |
| Q2 2016 | $1,000 | 0.0% | 46 | 0.0% | 0.00% | – |
| Q1 2016 | $1,000 | – | 46 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 694,232 | $8,532,000 | 5.82% |
| P.A.W. CAPITAL CORP | 400,000 | $4,916,000 | 4.34% |
| Telemetry Investments, L.L.C. | 128,848 | $1,584,000 | 2.68% |
| Trellus Management Company, LLC | 206,404 | $2,537,000 | 2.09% |
| KNOTT DAVID M | 295,035 | $3,626,000 | 1.64% |
| 683 Capital Management, LLC | 2,683,600 | $32,982,000 | 1.56% |
| INTERWEST VENTURE MANAGEMENT CO | 764,918 | $9,401,000 | 1.17% |
| TOWERVIEW LLC | 130,000 | $1,598,000 | 1.14% |
| Vivo Capital, LLC | 1,791,257 | $22,015,000 | 0.98% |
| Altium Capital Management LP | 197,500 | $2,427,000 | 0.91% |